Home › Occupations › Medical Scientists, Except Epidemiologists › Indianapolis, IN
Medical Scientists, Except Epidemiologists in Indianapolis, IN: H-1B salaries
147 labor condition applications for this occupation with a work site in Indianapolis, IN. Median offered base salary $68,964; middle half $61,884–$83,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $65,000 |
| Level II (qualified) | $82,500 |
| Level III (experienced) | $128,125 |
| Level IV (fully competent) | $174,046 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Indiana University Indianapolis | 69 | $68,215 |
| Indiana University Purdue University Indianapolis | 47 | $63,920 |
| Eli Lilly and Company | 21 | $145,346 |
| Purdue University | 3 | $58,812 |
| Indiana Biosciences Research Institute, Inc. | 2 | $120,000 |
| IU Health Care Associates | 2 | — |
| Neurohealth Ltd LLC | 1 | $60,798 |
| Cook Research Inc. | 1 | $100,000 |
| IQVIA Laboratories LLC | 1 | $121,673 |
Job titles
- Postdoctoral Fellow58
- Assistant Research Professor38
- Assistant Research Scientist5
- Senior Staff Scientist2
- Sr. Director - Clinical Development2
- Assistant Professor of Clinical Pathology & Laboratory Medic2
- Assistant Professor Medical Physicist2
- Assistant Professor2
- Executive Director - Clinical Research Physician2
- Post-Doctoral Research Assistant2
- Assistant Research Professor of Medicine2
- Research Data Analyst2
- Post-Doctoral Scientist - Neurodegeneration2
- Clinical Design Physician-Immunology2
- Medical Scientist2
H-1B sponsors in Indianapolis, IN →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).